News Agency
Men's Weekly

Alterity Therapeutics Announces Publication Demonstrating that ATH434 is Neuroprotective in Animal Model of Parkinsonian Disorder in the Journal of Parkinson's Disease

  • Written by PR Newswire

Study demonstrates reduction of α-synuclein aggregation and preservation of neurons

Alterity Therapeutics Announces Publication Demonstrating that ATH434 is Neuroprotective in Animal Model of Parkinsonian Disorder in the Journal of Parkinson's Disease

MELBOURNE, Australia, Jan. 28, 2022 /PRNewswire/ -- Alterity Therapeutics (ASX: ATH, NASDAQ: ATHE) ("Alterity" or "the Company"), a biotechnology company dedicated to developing disease modifying treatments for neurodegenerative diseases, today...

Read more: Alterity Therapeutics Announces Publication Demonstrating that ATH434 is Neuroprotective in Animal...

The Role of Stainless Steel Suppliers in Australia’s Industry

Stainless steel has become a cornerstone of modern industry, valued for its strength, durability, and resistance to corrosion. From construction and manufacturing to kitchenware and medical equipment, stainless steel plays a vital role in countless applications. Central to this supply... Read more

Writers Wanted



NewsServices.com

Content & Technology Connecting Global Audiences

More Information - Less Opinion